EN | RU
EN | RU

Help Support

Back

Vaccination can improve COVID-19 immunity in people with mild or asymptomatic earlier infection

Vaccination can improve COVID-19 immunity in people with mild or asymptomatic earlier infection Vaccination can improve COVID-19 immunity in people with mild or asymptomatic earlier infection
Vaccination can improve COVID-19 immunity in people with mild or asymptomatic earlier infection Vaccination can improve COVID-19 immunity in people with mild or asymptomatic earlier infection

What's new?

Administration of a single vaccine can be beneficial in people with a history of COVID infection.

A research published in the International Journal of Infectious Diseases demonstrated that a single BNT162b2 mRNA vaccine dose in patients suffering from mild or asymptomatic previous infection can more effectively boost SARS-CoV-2 humoral immunity to levels greater in comparison with those procured by complete two-vaccination in uninfected individuals.

Ilaria Vicenti and investigators evaluated the SARS-CoV-2 neutralizing antibody (NtAb) titres in earlier infected (mild or asymptomatic infection; n=41) or uninfected (n=16) health care workers who received 1 or 2 doses of vaccine. The NtAbs were titrated as dose-inhibiting 50% of the virus replication (ID50). The assessment was performed at the first vaccination dose (T1_inf) and after 21 days (T2_inf). In uninfected individuals, assessments were done at 20 days following the first (T2_uninf) and 20 days following the second dose (T3_uninf).

A noteworthy link between days from diagnosis and NtAb levels at T2_inf was found. NtAb titres increased at different assessment times in infected and uninfected individuals, as shown in Table 1:


Nevertheless, the levels of NtAb at T2_inf were considerably greater as compared to at T2_uninf and T3_uninf. Thus, vaccination of individuals having mild or asymptomatic prior infection further enhances SARS-CoV-2 immunity. 

Source:

International Journal of Infectious Diseases: IJID

Article:

Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection

Authors:

Ilaria Vicenti et al.

Comments (1)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ua en ru
Try: